Entrada Therapeutics, Inc.TRDANASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-156.00M
↓ 265% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-42.72M
Historical baseline
PeriodValueYoY Change
2025$-156.00M-431.8%
2024$47.01M+1586.7%
2023$-3.16M+96.7%
2022$-97.25M-90.2%
2021$-51.13M-91.7%
2020$-26.67M-125.5%
2019$-11.82M-